Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone
about
Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Decitabine priming prior to lo ...... nalysis vs. chemotherapy alone
@en
Decitabine priming prior to lo ...... alysis vs. chemotherapy alone.
@nl
type
label
Decitabine priming prior to lo ...... nalysis vs. chemotherapy alone
@en
Decitabine priming prior to lo ...... alysis vs. chemotherapy alone.
@nl
prefLabel
Decitabine priming prior to lo ...... nalysis vs. chemotherapy alone
@en
Decitabine priming prior to lo ...... alysis vs. chemotherapy alone.
@nl
P2093
P2860
P1476
Decitabine priming prior to lo ...... nalysis vs. chemotherapy alone
@en
P2093
Gaixiang Xu
Haitao Meng
Hongyan Tong
Jiejing Qian
Juying Wei
P2860
P2888
P304
P356
10.1007/S00432-016-2331-0
P577
2017-01-20T00:00:00Z